Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
1(9%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
9%
Ph not_applicable
10
91%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution11 total trials
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(7)
Other(1)

Detailed Status

Completed7
Enrolling by invitation1
Recruiting1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (9.1%)
N/A10 (90.9%)

Trials by Status

enrolling_by_invitation19%
recruiting19%
completed764%
not_yet_recruiting19%
unknown19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
OTHER
Total Trials
11